Gentiva Health price target raised to $19 from $16 at SunTrust SunTrust increased its price target on Gentiva after the company's results surpassed expectations and the company's preannouncement. The firm thinks the results were strong but keeps a Neutral rating on the shares.
Gentiva Health stockholders approve combo with Kindred Healthcare Gentiva Health Services (GTIV) announced that all proposals necessary for the combination with Kindred Healthcare (KND) were approved by Gentiva’s stockholders at the company’s Special Meeting of Stockholders. Gentiva and Kindred expect to complete the transaction on February 2. As previously announced, on October 9, Kindred and Gentiva entered into a definitive agreement under which Kindred will combine with Gentiva for $14.50 per share in cash and 0.257 shares of Kindred common stock based upon an agreed upon fixed exchange ratio.